. 2016 Dec 7;6(1):1–8. doi: 10.1530/EC-16-0081
This work is licensed under a Table 2.
Cohorts of patients with AI from the EU-AIR with prednisolone or hydrocortisone replacement therapy used for the matching process (for age, sex, duration and type of disease (PAI or SAI)).
| Before matching | After matching | |||
|---|---|---|---|---|
| Variable | Prednisolone (n = 50) | Hydrocortisone (n = 909) | Prednisolone (n = 47) | Hydrocortisone (n = 141) |
| Age (years) | 58.5 (16.6) | 54.2 (16.2) | 58.0 (16.6) | 60.0 (14.4) |
| Duration of disease (years) | 25.1 (13.6) | 15.4 (11.0) | 23.0 (10.3) | 23.1 (10.2) |
| Female (%) | 62.0 | 50.8 | 61.7 | 61.7 |
| PAI (%) | 40.0 | 30.9 | 40.4 | 40.4 |
Data show mean (±s.d.) unless otherwise indicated.
AI, adrenal insufficiency; EU-AIR, European Adrenal Insufficiency Registry; PAI, primary adrenal insufficiency; SAI, secondary adrenal insufficiency; s.d., standard deviation.